このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Hikma Pharmaceuticals 配当金
配当金 基準チェック /56
Hikma Pharmaceuticals配当を支払う会社であり、現在の利回りは2.83%で、収益によって十分にカバーされています。
主要情報
3.1%
配当利回り
84%
配当性向
| 業界平均利回り | 2.2% |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | n/a |
| 一株当たり利益 | UK£0.86 |
| 3年後の配当利回り予想 | 3.5% |
最近の配当金アップデート
Recent updates
Is Hikma Pharmaceuticals PLC (LON:HIK) Trading At A 29% Discount?
Apr 24
Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Apr 02Hikma Pharmaceuticals PLC's (LON:HIK) Share Price Matching Investor Opinion
Feb 25Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?
Dec 27An Intrinsic Calculation For Hikma Pharmaceuticals PLC (LON:HIK) Suggests It's 43% Undervalued
Dec 12Hikma Pharmaceuticals (LON:HIK) Has A Pretty Healthy Balance Sheet
Sep 19Calculating The Intrinsic Value Of Hikma Pharmaceuticals PLC (LON:HIK)
Sep 01Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Jun 21Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 28% Above Its Share Price
Jun 02Hikma Pharmaceuticals (LON:HIK) Has A Pretty Healthy Balance Sheet
Mar 14Calculating The Intrinsic Value Of Hikma Pharmaceuticals PLC (LON:HIK)
Feb 21Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?
Sep 27Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 19% Below Its Share Price
Jun 24These 4 Measures Indicate That Hikma Pharmaceuticals (LON:HIK) Is Using Debt Reasonably Well
Jun 06Here's Why Hikma Pharmaceuticals (LON:HIK) Can Manage Its Debt Responsibly
Feb 26Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 92% Above Its Share Price
Dec 01Is Hikma Pharmaceuticals (LON:HIK) Using Too Much Debt?
Nov 11Is There An Opportunity With Hikma Pharmaceuticals PLC's (LON:HIK) 32% Undervaluation?
Sep 02Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Aug 09Hikma Pharmaceuticals PLC (LON:HIK) Shares Could Be 26% Below Their Intrinsic Value Estimate
May 21Hikma Pharmaceuticals (LON:HIK) Seems To Use Debt Quite Sensibly
May 03It's Unlikely That Hikma Pharmaceuticals PLC's (LON:HIK) CEO Will See A Huge Pay Rise This Year
Apr 16How Does Hikma Pharmaceuticals PLC (LON:HIK) Stand Up To These Simple Dividend Safety Checks?
Apr 13Hikma Pharmaceuticals PLC (LON:HIK) Looks Interesting, And It's About To Pay A Dividend
Mar 14Hikma Pharmaceuticals PLC Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Feb 28I Ran A Stock Scan For Earnings Growth And Hikma Pharmaceuticals (LON:HIK) Passed With Ease
Feb 22Is There An Opportunity With Hikma Pharmaceuticals PLC's (LON:HIK) 23% Undervaluation?
Feb 03決済の安定と成長
配当データの取得
安定した配当: HIKの1株当たり配当金は過去10年間安定しています。
増加する配当: HIKの配当金は過去10年間にわたって増加しています。
配当利回り対市場
| Hikma Pharmaceuticals 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (HIK) | 3.1% |
| 市場下位25% (GB) | 2.0% |
| 市場トップ25% (GB) | 5.6% |
| 業界平均 (Pharmaceuticals) | 2.2% |
| 3年後のアナリスト予想 (HIK) | 3.5% |
注目すべき配当: HIKの配当金 ( 2.83% ) はUK市場の配当金支払者の下位 25% ( 2.06% ) よりも高くなっています。
高配当: HIKの配当金 ( 2.83% ) はUK市場の配当金支払者の上位 25% ( 5.66% ) と比較すると低いです。
株主への利益配当
収益カバレッジ: 現在の配当性向（ 83.7% ）では、 HIKの支払いは利益によってカバーされています。
株主配当金
キャッシュフローカバレッジ: HIKの 現金配当性向 ( 39.5% ) は比較的低く、配当金の支払いはキャッシュフローによって十分にカバーされています。